Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lineage

44.55
+0.43000.97%
Post-market: 44.550.00000.00%19:31 EDT
Volume:488.17K
Turnover:21.76M
Market Cap:10.18B
PE:-14.03
High:45.10
Open:44.49
Low:43.75
Close:44.12
Loading ...

MASTER LOCK® UNVEILS INDUSTRY-LEADING PREMIUM 2-HOUR FIREPROOF SAFE LINE FOR UNPARALLELED PROTECTION

PR Newswire
·
02 Apr

Lineage finalizes acquisition of Bellingham Cold Storage

FreightWaves
·
02 Apr

Lineage Buys Three Warehouses From Bellingham Cold Storage

MT Newswires Live
·
02 Apr

BRIEF-Lineage Announces Acquisition Of Bellingham Cold Storage

Reuters
·
02 Apr

Lineage Announces Acquisition of Bellingham Cold Storage

THOMSON REUTERS
·
02 Apr

Lineage Announces Acquisition of Bellingham Cold Storage

Business Wire
·
02 Apr

Lineage Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
02 Apr

Lineage price target lowered to $75 from $80 at Morgan Stanley

TIPRANKS
·
01 Apr

FACTBOX-Hot or not? How recent high-profile US IPOs have performed

Reuters
·
28 Mar

Lineage Initiated at Neutral by Citigroup

Dow Jones
·
28 Mar

Citigroup Initiates Lineage at Neutral With $64 Price Target

MT Newswires Live
·
28 Mar

Lineage Inc : Citigroup Initiates Coverage With Neutral Rating; Price Target $64

THOMSON REUTERS
·
28 Mar

The blogger who was right about Nvidia is now panning a $25 billion AI company

Dow Jones
·
21 Mar

Press Release: PREFORMED LINE PRODUCTS ANNOUNCES QUARTERLY DIVIDEND

Dow Jones
·
20 Mar

Lineage Keeps Quarterly Dividend at $0.5275 per Share; Payable April 21 to Shareholders as of March 31

MT Newswires Live
·
19 Mar

Lineage, Inc. Declares Dividend for First Quarter 2025

Business Wire
·
19 Mar

WONDER EXPANDS ICONIC BRAND WITH NEW LINE OF SWEET TREATS

PR Newswire
·
17 Mar

VALUE LINE, INC. ANNOUNCES EARNINGS FOR FIRST NINE MONTHS OF FISCAL 2025

GlobeNewswire
·
15 Mar

Lineage Cell Therapeutics Is Maintained at Buy by B. Riley Securities

Dow Jones
·
14 Mar

Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley

TIPRANKS
·
14 Mar